93 related articles for article (PubMed ID: 30959047)
21. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis signal-regulating kinase (ASK1) and transcription factor tumor suppressor protein TP53 suppress rabbit ovarian granulosa cell functions.
Sirotkin AV; Petrak J; Alwasel S; Harrath AH
Anim Reprod Sci; 2019 May; 204():140-151. PubMed ID: 30948244
[TBL] [Abstract][Full Text] [Related]
23. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
[TBL] [Abstract][Full Text] [Related]
24. New Mammalian Target of Rapamycin (mTOR) Modulators Derived from Natural Product Databases and Marine Extracts by Using Molecular Docking Techniques.
Ruiz-Torres V; Losada-Echeberría M; Herranz-López M; Barrajón-Catalán E; Galiano V; Micol V; Encinar JA
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30326670
[TBL] [Abstract][Full Text] [Related]
25. The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.
De Martino MC; van Koetsveld PM; Feelders RA; Sprij-Mooij D; Waaijers M; Lamberts SW; de Herder WW; Colao A; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2012 Jun; 19(3):351-64. PubMed ID: 22420007
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor p53 can regulate proliferation, apoptosis and secretory activity of luteinizing porcine ovarian granulosa cell cultured with and without ghrelin and FSH.
Sirotkin AV; Benco A; Tandlmajerova A; Vasícek D; Kotwica J; Darlak K; Valenzuela F
Reproduction; 2008 Nov; 136(5):611-8. PubMed ID: 18703674
[TBL] [Abstract][Full Text] [Related]
28. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
29. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment.
Brockmueller A; Buhrmann C; Shayan P; Shakibaei M
Front Immunol; 2023; 14():1225530. PubMed ID: 37575245
[TBL] [Abstract][Full Text] [Related]
31. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
[TBL] [Abstract][Full Text] [Related]
32. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation.
Cao M; Zhang Z; Han S; Lu X
Mol Med Rep; 2019 May; 19(5):3941-3947. PubMed ID: 30864709
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds.
Huang Q; Xie L; Chen X; Yu H; Lv Y; Huang X; Ying J; Zheng C; Cheng Y; Huang J
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800123. PubMed ID: 30357890
[TBL] [Abstract][Full Text] [Related]
34. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
35. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin.
Benco A; Sirotkin AV; Vasícek D; Pavlová S; Zemanová J; Kotwica J; Darlak K; Valenzuela F
Reproduction; 2009 Sep; 138(3):553-60. PubMed ID: 19528263
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells.
Miyake N; Chikumi H; Takata M; Nakamoto M; Igishi T; Shimizu E
Oncol Rep; 2012 Sep; 28(3):848-54. PubMed ID: 22710790
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
[TBL] [Abstract][Full Text] [Related]
40. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
